Annual Long Term Debt
$1.57 M
-$550.00 K-25.94%
31 March 2024
Summary:
VistaGen Therapeutics annual long term debt is currently $1.57 million, with the most recent change of -$550.00 thousand (-25.94%) on 31 March 2024. During the last 3 years, it has fallen by -$1.78 million (-53.15%). VTGN annual long term debt is now -67.20% below its all-time high of $4.79 million, reached on 31 March 2014.VTGN Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$1.27 M
-$154.00 K-10.82%
30 September 2024
Summary:
VistaGen Therapeutics quarterly long term debt is currently $1.27 million, with the most recent change of -$154.00 thousand (-10.82%) on 30 September 2024. Over the past year, it has dropped by -$591.50 thousand (-31.79%). VTGN quarterly long term debt is now -82.78% below its all-time high of $7.37 million, reached on 30 September 2014.VTGN Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTGN Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.9% | -31.8% |
| 3 y3 years | -53.1% | -59.6% |
| 5 y5 years | +10000.0% | -67.3% |
VTGN Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -53.1% | at low | -59.6% | at low |
| 5 y | 5 years | -57.8% | >+9999.0% | -67.3% | at low |
| alltime | all time | -67.2% | >+9999.0% | -82.8% | >+9999.0% |
VistaGen Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.27 M(-10.8%) |
| June 2024 | - | $1.42 M(-9.4%) |
| Mar 2024 | $1.57 M(-25.9%) | $1.57 M(-8.7%) |
| Dec 2023 | - | $1.72 M(-7.6%) |
| Sept 2023 | - | $1.86 M(-6.8%) |
| June 2023 | - | $2.00 M(-5.8%) |
| Mar 2023 | $2.12 M(-18.6%) | $2.12 M(-6.0%) |
| Dec 2022 | - | $2.25 M(-5.2%) |
| Sept 2022 | - | $2.38 M(-4.8%) |
| June 2022 | - | $2.50 M(-4.0%) |
| Mar 2022 | $2.61 M(-22.2%) | $2.61 M(-4.1%) |
| Dec 2021 | - | $2.72 M(-13.5%) |
| Sept 2021 | - | $3.14 M(-3.5%) |
| June 2021 | - | $3.25 M(-2.9%) |
| Mar 2021 | $3.35 M(-9.9%) | $3.35 M(-2.8%) |
| Dec 2020 | - | $3.45 M(-5.0%) |
| Sept 2020 | - | $3.63 M(-3.4%) |
| June 2020 | - | $3.76 M(+1.1%) |
| Mar 2020 | $3.72 M(>+9900.0%) | $3.72 M(-2.2%) |
| Dec 2019 | - | $3.80 M(-2.1%) |
| Sept 2019 | - | $3.88 M(-2.0%) |
| June 2019 | - | $3.96 M(>+9900.0%) |
| Mar 2019 | $6300.00 | $6300.00(-11.3%) |
| Dec 2018 | - | $7100.00(-10.1%) |
| Sept 2018 | - | $7900.00(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $8600.00(-7.5%) |
| Mar 2018 | $9300.00(-21.8%) | $9300.00(-7.0%) |
| Dec 2017 | - | $10.00 K(-6.5%) |
| Sept 2017 | - | $10.70 K(-5.3%) |
| June 2017 | - | $11.30 K(-5.0%) |
| Mar 2017 | $11.90 K(-56.3%) | $11.90 K(-56.3%) |
| Mar 2016 | $27.20 K(-91.8%) | $27.20 K(-8.1%) |
| Dec 2015 | - | $29.60 K(-7.5%) |
| Sept 2015 | - | $32.00 K(-96.9%) |
| June 2015 | - | $1.04 M(+212.2%) |
| Mar 2015 | $332.90 K(-93.0%) | $332.90 K(-93.0%) |
| Dec 2014 | - | $4.75 M(-35.6%) |
| Sept 2014 | - | $7.37 M(+42.8%) |
| June 2014 | - | $5.16 M(+7.8%) |
| Mar 2014 | $4.79 M(+3.4%) | $4.79 M(-12.5%) |
| Dec 2013 | - | $5.47 M(+5.9%) |
| Sept 2013 | - | $5.17 M(+6.4%) |
| June 2013 | - | $4.86 M(+4.9%) |
| Mar 2013 | $4.63 M(+64.9%) | $4.63 M(+7.5%) |
| Dec 2012 | - | $4.30 M(+79.6%) |
| Sept 2012 | - | $2.40 M(-0.0%) |
| June 2012 | - | $2.40 M(-14.6%) |
| Mar 2012 | $2.81 M | $2.81 M(+3.0%) |
| Dec 2011 | - | $2.73 M(-3.1%) |
| Sept 2011 | - | $2.82 M(-4.2%) |
| June 2011 | - | $2.94 M |
FAQ
- What is VistaGen Therapeutics annual long term debt?
- What is the all time high annual long term debt for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual long term debt year-on-year change?
- What is VistaGen Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly long term debt year-on-year change?
What is VistaGen Therapeutics annual long term debt?
The current annual long term debt of VTGN is $1.57 M
What is the all time high annual long term debt for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual long term debt is $4.79 M
What is VistaGen Therapeutics annual long term debt year-on-year change?
Over the past year, VTGN annual long term debt has changed by -$550.00 K (-25.94%)
What is VistaGen Therapeutics quarterly long term debt?
The current quarterly long term debt of VTGN is $1.27 M
What is the all time high quarterly long term debt for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly long term debt is $7.37 M
What is VistaGen Therapeutics quarterly long term debt year-on-year change?
Over the past year, VTGN quarterly long term debt has changed by -$591.50 K (-31.79%)